Bumper Offer - Urjas oil Just @ Rs. 1
Riflect 400 Tablet is a commercial drug that is prescribed in the form of Tablet. Primarily, it is used for the treatment of Hepatic Encephalopathy. Riflect 400 Tablet also has some secondary and off-label uses. These are listed below.
Medical history of the patient along with age and gender determines the dosage of Riflect 400 Tablet. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. This information has been provided in detail in the dosage section.
The most common side effects of Riflect 400 Tablet are Flatulence, Bloating or fullness, Constipation. While these are the most often observed Riflect 400 Tablet side effects, there are can be others also. These have been listed below. Such side effects of Riflect 400 Tablet normally do not last long and go away once the treatment is completed. Consult your doctor if these side effects become worse or stay for a longer duration.
Furthermore, you should know that effect of Riflect 400 Tablet is Severe for pregnant women and Severe for women who are breastfeeding. In addition, Riflect 400 Tablet's effects on the liver, heart and kidney are discussed below in the Riflect 400 Tablet related warnings section.
Other contraindications of Riflect 400 Tablet have been discussed in the sections ahead.
Additionally, Riflect 400 Tablet may also adversely react with other medicines. A complete list of these interactions is given below.
In addition to these precautions, you may also note that Riflect 400 Tablet is safe while driving, and is is addictive in nature.
Riflect 400 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| 13 - 18 years (Adolescent) |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Riflect 400 Tablet is used -
Moderate
Mild
Common
Is the use of Riflect 400 Tablet safe for pregnant women?
Riflect has many dangerous side effects in pregnant women. If you are pregnant, do not consume Riflect without medical advice.
Is the use of Riflect 400 Tablet safe during breastfeeding?
Riflect may cause serious side effects in breastfeeding women, so do not take this drug without doctor's advice.
What is the effect of Riflect 400 Tablet on the Kidneys?
Riflect is completely safe for kidneys.
What is the effect of Riflect 400 Tablet on the Liver?
Very few cases of side effects of Riflect on the liver have been reported.
What is the effect of Riflect 400 Tablet on the Heart?
There are no any side effects of Riflect for the heart.
Riflect 400 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Riflect 400 Tablet unless your doctor advises you to do so -
Is this Riflect 400 Tablet habit forming or addictive?
No, you will not get addicted to Riflect 400 Tablet.
Is it safe to drive or operate heavy machinery when consuming?
Yes, you can operate a vehicle or heavy machinery after taking Riflect 400 Tablet since it does not cause drowsiness.
Is it safe?
Yes, but take Riflect 400 Tablet only as per medical advice.
Is it able to treat mental disorders?
Riflect 400 Tablet is unable to treat or cure mental disorders.
Interaction between Food and Riflect 400 Tablet
You can take Riflect 400 Tablet with food.
Interaction between Alcohol and Riflect 400 Tablet
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Riflect 400 Tablet.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Xifaxan® (rifaximin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 681-683
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1096-1097
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Xifaxan® (rifaximin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 681-683
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1096-1097
